Effect of ACE inhibitors on the atrial natriuretic peptides in heart failure

Affiliations

Comment

A D Struthers. Br Heart J. 1994 Dec.

. 1994 Dec;72(6):504.

doi: 10.1136/hrt.72.6.504.

¹ Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee.

No abstract available

Comment on

Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.
Berglund H, Nyquist O, Beermann B, Jensen-Urstad M, Theodorsson E. Berglund H, et al. Br Heart J. 1994 Dec;72(6):521-7. doi: 10.1136/hrt.72.6.521. Br Heart J. 1994. PMID: 7857733 Free PMC article. Clinical Trial.
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Yoshimura M, Yasue H, Tanaka H, Kikuta K, Sumida H, Kato H, Jougasaki M, Nakao K. Yoshimura M, et al. Br Heart J. 1994 Dec;72(6):528-33. doi: 10.1136/hrt.72.6.528. Br Heart J. 1994. PMID: 7857734 Free PMC article. Clinical Trial.